Nationwide, more than one-third of total primary care physicians (PCPs) are working with their regional extension centers (REC) to adopt electronic health records (EHRs), according to the U.S. Department of Health & Senior Services.
Half of these providers are in small group practices or consortia of small group practices. The other half is made up of community health centers (18%), public hospitals (11%); the remaining 21% are in various underserved settings.
The nation's 62 RECs assist PCPs in meeting meaningful use through the Medicare and Medicaid EHR Incentive Programs. So far they have helped more than half of the targeted 1,776 critical access and rural hospitals, according to HHS.
Read more at: http://tinyurl.com/7ba7pkg
Sources: Becker's Hospital Review; U.S. Department of Health & Human Services
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Gestational Diabetes Is a Key Population Health Opportunity
December 7th 2023Diagnosing and treating gestational diabetes can have long-term positive effects on the health of the mother and the baby, warranting a distinct focus on the condition, according to an Institute for Value-Based Medicine® event held in Cleveland, Ohio.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More